Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flucloxacillin with or without phenoxymethylpenicillin for cellulitis
NCT02922686Phase 4Unknown
- Sponsor
- Royal College of Surgeons of England
- Start
- Dec 2016
- Primary completion
- Dec 2019
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of phenoxymethylpenicillin in cellulitis, Wound infection (WI), abscess, acute bacterial skin and skin structure infections (ABSSSI), sponsored by Royal College of Surgeons of England. Status: unknown.
02
Drugs
phenoxymethylpenicillin
03
Conditions
cellulitisWound infection (WI)abscessacute bacterial skin and skin structure infections (ABSSSI)
Beyond the preview
Go deeper on NCT02922686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02922686.